Randall J. Bateman
Papers
2
Total Citations
26
H-Index
2
About
Randall J. Bateman is a pioneering neuroscientist whose research focuses on the molecular mechanisms of Alzheimer’s disease, particularly the metabolism of amyloid-beta and tau proteins. He is best known for developing the first in vivo human stable isotope labeling technique (SILK), which enables real-time measurement of protein production and clearance in the central nervous system—a breakthrough that has fundamentally reshaped our understanding of Alzheimer’s pathogenesis. His work has been cited over 30,000 times, reflecting its profound impact on both basic science and clinical trials. Bateman also led the landmark Dominantly Inherited Alzheimer Network (DIAN) study, which tracks families with genetic mutations causing early-onset Alzheimer’s, providing critical insights into disease progression decades before symptoms emerge. His contributions have guided the development of anti-amyloid therapies and biomarkers for early detection. In addition to his research, Bateman is a dedicated mentor and advocate for open science, making him a central figure in the global effort to combat Alzheimer’s disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2